Reviewed by Ashley Harwyn, PA-C, ABAAHP | A4M Board Certified | Updated October 2, 2026
A lipid panel is one of the most useful heart tests, and advanced markers help in the right situation. Here is what each measures and when it is worth doing.
Used well, advanced markers like apolipoprotein B (ApoB) and lipoprotein(a), written Lp(a), can sharpen a picture the standard numbers leave fuzzy, especially when your risk is borderline, your family history is concerning, or your results do not add up.[1][3] We will tell you honestly which of these you actually need, treat the numbers that matter, and skip the ones that would not change your plan.
- A standard lipid panel measures LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides, and together with your risk factors it guides most cholesterol decisions.[1][5]
- ApoB counts the actual number of artery-clogging particles, and it predicts risk better than LDL cholesterol when the two disagree, which makes it useful in selected cases.[1]
- Lp(a) is a mostly genetic, lifelong risk factor that a standard panel misses, and guidelines suggest measuring it at least once in adulthood.[3]
- High Lp(a), around 50 mg/dL (125 nmol/L) or higher, is linked to roughly a 1.4-fold higher long-term risk of heart attack or stroke, and it stays stable over your life, so one test usually answers the question.[3]
- Advanced testing is selective, not universal: for many people a standard panel plus a risk estimate is enough, and more markers do not automatically mean better care.[1][2]
- What matters is pairing the right test with an honest read of your overall cardiovascular risk, then treating the drivers that actually move it.[2]
What a lipid panel measures
Start with the standard panel, because it does most of the work. It measures LDL cholesterol, the “bad” cholesterol that can build up in artery walls; HDL cholesterol, the “good” cholesterol that helps clear it; and triglycerides, a blood fat tied to diet, weight, and metabolic health.[5] From those, your clinician can also read your non-HDL cholesterol, which captures all the harmful particles in one number. For a large share of people, these values plus your blood pressure, blood sugar, age, and history are enough to estimate your risk and decide whether treatment helps.[2]
Cholesterol itself is not the enemy. Your body needs it to build cell membranes, hormones, and vitamin D. The problem is a surplus of the particles that deposit in artery walls, and that is what lipid testing is really measuring: not a single villain, but the balance of particles that either drive or protect against heart disease. Getting that balance right, through lifestyle and, for the right person, medication, is one of the highest-value things you can do for your long-term health.
The reason the panel matters is that it feeds a decision, not just a number. For adults aged 40 to 75 with risk factors and an estimated 10-year cardiovascular risk of 10 percent or higher, a statin is recommended because the benefit is well established, and your lipid results are a central input to that calculation.[4] In other words, the value of knowing your LDL is not the number on the page, it is whether it tips you across a threshold where treatment clearly helps. That is why we never read a lipid result in isolation: the same LDL can call for aggressive treatment in one person and simple monitoring in another, depending on everything else going on. A test that is not connected to a decision is just data, and data alone does not protect anyone's heart.
Measures a standard panel, reads it against your overall cardiovascular risk, and adds a targeted advanced marker like Lp(a) or ApoB only when it will actually change the plan, then treats the drivers that matter.
Running the fanciest panel on everyone, treating numbers without the context of overall risk, and charging for advanced markers that do not change a single decision, which adds cost and worry, not clarity.
When advanced lipid testing adds something
Here is where honesty matters, because “advanced” testing is often sold as universally better when it is really a set of targeted tools. Here are the advanced markers people ask about most, with what each one adds and when it earns a place on your lab order.
| Marker | What it adds | When it is worth measuring |
|---|---|---|
| ApoB | Counts atherogenic particles directly; beats LDL when they disagree | Borderline risk, high triglycerides, or discordant results[1] |
| Lp(a) | A mostly genetic, lifelong risk factor a standard panel misses | At least once in adulthood, especially with family history[3] |
| Particle number or size | Detail on how many and how dense the LDL particles are | When standard numbers do not match the clinical picture |
| hsCRP (inflammation) | A marker of vascular inflammation that can refine risk | Selected cases where it would change the decision[2] |
Six reasons a marker might matter
Mark the statements that fit you. The more that fit, the more likely one targeted marker will change your plan instead of adding another number to your chart.
Two things stand out. First, each advanced marker answers a specific question, so the right move is to order the one that fits your situation, not all of them by default. Second, the most important of these for many people is Lp(a), precisely because it is genetic, lifelong, and invisible on a standard panel, and because one measurement usually settles it.[3]
The honest limits of more testing
Premium panels are rarely sold with this caveat attached. For a large share of people, a standard lipid panel combined with an honest cardiovascular risk estimate is genuinely enough to make good decisions, and piling on advanced markers adds cost without changing the plan.[2] The professional guidelines treat markers like ApoB as something to consider when risk-enhancing factors would actually alter management, not as a routine add-on for everyone.[1]
That does not make advanced testing pointless. It makes it selective. The skill is knowing when an extra marker will change what you do, such as an elevated Lp(a) that justifies treating other risk factors more aggressively, or an ApoB that reveals more risk than the LDL suggested, and ordering it then. A test that does not change your plan is not thoroughness, it is noise, and noise can lead to worry and overtreatment. We would rather run the right test and act on it than run every test and act on none of them.
Not sure which lipid tests you actually need? That is exactly the question to answer before paying for a premium panel. Call 843-981-0870 and we will run the right panel, read it against your real risk, and add an advanced marker only where it changes the plan.
Lipid testing at Solcara, Mount Pleasant and Charleston
Most people are best served by a standard lipid panel interpreted alongside their overall risk, with an advanced marker such as ApoB or Lp(a) added only when it would change the plan. A good clinic measures your lipids, estimates your cardiovascular risk, decides whether an advanced marker like Lp(a) or ApoB would actually help, and then treats the drivers that matter.
If you have older lipid results, bring them, since a trend across several years says more than a single draw. Either office works for this, Mount Pleasant or the downtown Longevity Club. Ashley Harwyn, PA-C reads your lipids alongside your full picture, orders the advanced marker that fits your situation, and connects the result to a real plan through our cardiac prevention and comprehensive labs. The point is a heart plan you can measure, not a bigger bill.
Cardiac Health
Where your lipid numbers turn into a real risk assessment. Read Cardiac Health.
Annual Full Panel Labs
How lipids fit into your whole health picture. Read Annual Full Panel Labs.
Medical Weight Management
One of the most effective ways to improve triglycerides and risk. Read Medical Weight Management.
If you want to see why the standard panel falls short
Read heart disease after menopause, which walks through ApoB and Lp(a).
Ashley Harwyn, PA-C
PA-C, ABAAHP · Founder, Solcara Health
Online
Tap a question to ask
Be taken seriously, and told the truth
Book an evaluation at The Longevity Club, 163 Rutledge Avenue downtown, or our Mount Pleasant office.
BOOK A CONSULTATION →Or call 843-981-0870
Ashley Harwyn, PA-C, ABAAHP
Founder, Solcara Health · Diplomate, American Board of Anti-Aging Health Practitioners (ABAAHP)
Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.
Full bio →References
The 2018 AHA/ACC blood cholesterol guideline, the 2019 ACC/AHA primary prevention guideline, an American College of Cardiology update on lipoprotein(a), the US Preventive Services Task Force statin statement, and the National Library of Medicine MedlinePlus cholesterol resource, each accessed October 2, 2026.
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019. ahajournals.org
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019. ahajournals.org
- American College of Cardiology. An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations. 2023. acc.org
- U.S. Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. 2022. uspreventiveservicestaskforce.org
- MedlinePlus, National Library of Medicine. Cholesterol Levels. medlineplus.gov
Medical Disclaimer: This page is for educational and informational purposes only and does not constitute medical advice, and reading it does not create a patient-provider relationship. It describes general medical information and categories of care, not a recommendation that any individual start, stop, or change any test, treatment, or medication. Any diagnosis or treatment decision requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of October 2, 2026.
Ashley Harwyn, PA-C, ABAAHP, is a Diplomate of the American Board of Anti-Aging Health Practitioners (ABAAHP) through A4M and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).




Advanced Lipid Testing FAQ's

Quick Links

.png)